What Is MOTS-C?

MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded by mitochondrial DNA. It is discussed in metabolism, exercise, insulin sensitivity, and aging-related research. It is not FDA-approved for human wellness, weight loss, anti-aging, or performance enhancement.

How It Works

MOTS-C is studied as a mitochondrial signaling peptide that may influence AMPK-related pathways, metabolic stress response, skeletal muscle metabolism, insulin sensitivity, and exercise-associated adaptation in preclinical research. These mechanisms are promising but are not marketed as proven clinical benefits.

What It’s Studied For

Research has explored MOTS-C in metabolic homeostasis, insulin sensitivity, obesity models, exercise response, and age-related physical decline. Human clinical exposure data remain limited. FDA has identified concerns for compounded MOTS-C, including immunogenicity, peptide impurities, active-ingredient characterization, and lack of identified human exposure data for proposed routes.

How It May Be Used in a Clinician-Supervised Program

A licensed clinician may discuss MOTS-C only when legally available and clinically appropriate. Review may include metabolic history, diabetes risk, cardiovascular status, medication list, cancer history, immune status, pregnancy status, and expectations. MOTS-C is not a substitute for exercise, nutrition, diabetes care, or obesity treatment.

Preferred Starting Options / Dosing Notes

Many patients begin with a lower starting option so a licensed clinician can evaluate tolerance, medical history, goals, and safety factors before any adjustments are considered. The starting option shown below is informational and reflects available program data, not self-directed dosing instructions. Final medication, dose, frequency, and treatment plan are determined by a licensed clinician.

Safety Considerations

• Very limited human data and unknown long-term effects.
• Immune reaction risk and sterility/purity concerns.
• FDA-noted lack of sufficient human safety information.

Some treatments may involve compounded medications when prescribed by a clinician. Compounded medications are not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality before marketing.

Frequently Asked Questions